Olaparib monotherapy versus (vs) chemotherapy for germline BRCA-mutated (gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase III SOLO3 trial.
暂无分享，去创建一个
N. Colombo | G. Scambia | D. Cibula | E. Lowe | R. Penson | J. Nam | R. Mądry | L. Barker | C. Leath | C. Hernández | M. Bidziński | P. Mora | T. Milenkova | S. Ryu | R. V. Valencia | Jae Weon Kim